EU Court Dismisses AstraZeneca Appeal
The Court of Justice of the European Union has dismissed an appeal by AstraZeneca concerning a 2005 decision that found the company guilty of abusing its dominant position in the marketplace. More... |
| |
Court to Hear Solvay Pay-for-Delay Case
The US Supreme Court has agreed to hear a case that will decide whether brand-name drug companies may pay generic drug companies to delay introduction of lower-cost generic drugs. More... |
| |
Roche Collaborates on Stem Cell Project
Roche and the Innovative Medicines Initiative (IMI) have recently launched an academic-industry partnership, known as STEMBANCC, under which 10 pharmaceutical companies and 23 academic institutions will collaborate on using stem cell technology to accelerate the development of safer and more effective drugs for patients. More... |
| |
Biogen Idec and Isis Pharmaceuticals To Collaborate On Antisense Programs
Biogen Idec and Isis Pharmaceuticals have entered into a global collaboration agreement to discover and develop antisense drugs against three undisclosed targets to treat neurological or neuromuscular disorders. More... |
| |
Highlights from the PDA–EMA Joint Conference
Our scientific editor, Adeline Siew, recently attended the PDA–EMA joint conference in Cascais, Portugal. The conference focused on compliance, a prerequisite for availability of medicinal products, and kicked off with a plenary session on the impact of the new falsified medicines directive (FMD) on regulators and the pharmaceutical industry. More... |
| |
Get the Latest Updates on Twitter
We regularly tweet the latest news and rumours hitting the web about the pharmaceutical industry. Follow us to keep up to date. More... |
